Leiden University Medical Center (the Netherlands)
Department of Human Genetics

The Chancellor, Masters and Scholars of the University of Cambridge (UK)
Department of Public Health & Primary Care

Fundacion Centro Nacional de Investigaciones Oncologicas Carlos III (Spain)
Human Genetics Group, Human Cancer Genetics Programme

Lunds Universitet (Sweden)
Canceromics Branch, Division Oncology and Pathology

Universitaet Leipzig (Germany)
Institute for Medical Informatics, Statistics and Epidemiology

Servicio Madrileno de Salud (Spain)
Molecular Oncology Laboratory

Institut Curie (France)
Service de Genetique Oncologique

Universitaetsklinikum Koeln (Germany)

Karolinska Institutet (Sweden)
Dept. of Medical Epidemiology and Biostatistics

Region Hovedstaden

Bio-Prodict BV (NL)
Research and Development

Interactive Biosoftware SARL (France)
Research and Development

University of Melbourne (Australia)
Department of Pathology
Genetic Epidemiology Laboratory

University of Utah (USA)
Cancer Control and Population Sciences, Huntsman Cancer Institute

Queensland Institute of Medical Research (Australia)
Department of Genetics and Population Health

Mayo Clinic (USA)
Laboratory Medicine and Pathology

Universite Laval (Canada)
Centre de recherche du CHU de Québec
Department of Molecular Medicine

Agencia Estatal Consejo Superior Deinvestigationes Cientificas (Spain)
Department of Splicing and genetic susceptibility to cancer
Minigene Service

Dr. Mireille Broeders from the RadboudUMC in Nijmegen, The Nertherlands
Dr. Mirjam Plantinga from University of Groningen, the Netherlands.
Prof. Mark Robson from Memorial Sloan Kettering Cancer Center in New York, the USA
Elizabeth Bergsten-Nordstrom from BRO in Sundbyberg, Zweden